15 results found.

Hepatitis B, Chronic, or Tumor Clinical Trial using TDF

Chang Gung Memorial Hospital - Recruiting 18 years to 70 years.
- Phase IV; Different Extend Treatment Duration (6 Months vs 12 Months After Chemotherapy) to Prevent HBV Relapse With Tenofovir for Prophylaxis in Patients With Malignant Tumor Combined With HBV Carrier Receiving Chemotherapy.
TDF

Hepatitis B Chronic Infection, or Pregnancy Clinical Trial using tenofovir disoproxil fumarate; placebo

Institut de Recherche pour le Developpement - Recruiting 18 years or older.
- Phase 3, Randomized Clinical Trial to Assess the Efficacy and Safety of Tenofovir in Hepatitis B Virus Infected, s and e Antigen Positive, Pregnant Women to Prevent Perinatal Transmission Despite Infant Passive-active HBV Immunization..
tenofovir disoproxil fumarate; placebo

Hepatitis B, Cirrhosis, or Awaiting Organ Transplant Clinical Trial using HBV vaccine

Fundaci¢n P£blica Andaluza para la gesti¢n de la Investigaci¢n en Sevilla - Recruiting 18 years to 65 years.
- Open-label, Phase III, Randomized, Clinical Trial to Evaluate the Efficacy of Two Different Hepatitis B Virus (HBV) Vaccination Schemes in Patients With Hepatic Cirrhosis Candidates to Liver Transplantation.
HBV vaccine

Hepatitis C, Chronic Clinical Trial using Stop trial intervention for boceprevir, PEG-IFN and RBV

Kaohsiung Medical University Chung-Ho Memorial Hospital - Recruiting 20 years to 80 years.
- Boceprevir-based Triple Therapy to Rescue HCV Genotype 1/HBV Dually Infected Patients Refractory to Peginterferon Plus Ribavirin Combination Therapy.
Stop trial intervention for boceprevir, PEG-IFN and RBV

Hepatitis B Virus, or HIV Clinical Trial using Standard of care

University of North Carolina, Chapel Hill - Recruiting 18 years or older.
- CIDRZ-1220 Antiretroviral Treatment Outcomes in HIV-HBV Co-infected Patients in Southern Africa: a Collaborative Multi-country Prospective Cohort Analysis for International Epidemiologic Databases to Evaluate AIDS- Southern Africa (HIV/HBV-coinfection in IeDEA-SA).
Standard of care

Healthy Subjects, or Hepatitis B Clinical Trial using Hepatitis B Vaccine (Recombinant)

Rockefeller University - Recruiting 18 years to 60 years.
- Effects of Persistent Innate Immune Activation on Vaccine Efficacy Pilot Study: Gene Expression Profiling of Immune Response to HBV Vaccination in Healthy Volunteers.
Hepatitis B Vaccine (Recombinant)

HIV, or Hepatitis B Clinical Trial using Tenofovir/lamivudine/lopinavir-ritonavir; Zidovudine/lamivudine/lopinavir-ritonavir

Centers for Disease Control and Prevention - Recruiting 20 years or older.
- Maternal Tenofovir-containing Combination Drug Regimen During the Second and Third Trimesters of Pregnancy for Prevention of Mother-to-child Transmission of HIV and HBV in HIV-HBV Co-infected Mothers.
Tenofovir/lamivudine/lopinavir-ritonavir; Zidovudine/lamivudine/lopinavir-ritonavir

Hepatitis B, Chronic Clinical Trial using peginterferon alfa-2a [Pegasys]; nucleos(t)ide analogues

Hoffmann-La Roche - Recruiting 18 years to 65 years.
- A Phase IIb, Open Label, Single Arm, Multicenter Study to Evaluate the Effect of 48-weeks PEG-Interferon Alfa-2a (PEG-IFN) Administration on Serum HBsAg in Chronic Hepatitis B, HBeAg-Negative, Genotype D Patients on Treatment With Nucleos(t)Ide Analogues (NAs), Showing Stable HBV DNA Suppression.
peginterferon alfa-2a [Pegasys]; nucleos(t)ide analogues

Pregnancy, or HBV Clinical Trial using Tenofovir DF

Hopital LariboisiŠre - Recruiting 18 years or older.
- Prevention of Hepatitis B Virus (HBV) Mother-to-Child (MTC) Transmission by Serovaccination of Newborns and Use of Tenofovir DF During the Last Trimester of Pregnancy in Mothers With HBV DNA Above 100, 000 I.U/mL.
Tenofovir DF

HBV Infection Clinical Trial

Southwest Hospital, China - Recruiting 18 years to 65 years.
- The Effect of General Anesthesia Immunosuppressive on Hepatitis B Virus Replication.

Chronic Liver Disease, Non-Alcoholic Fatty Liver Disease, HCV Coi Clinical Trial using Shear Wave sonoelastography

Massachusetts General Hospital - Recruiting 18 years or older.
- Evaluate the Utility of Shear Wave Sonoelastography as a Tool to Measure Liver Fibrosis Grade..
Shear Wave sonoelastography

HBV, or Chronic HBV Infections Clinical Trial using Tenofovir alafenamide; Tenofovir DF; Placebo to match tenofovir alafenamide; Placebo to match tenofovir DF

Gilead Sciences - Recruiting 18 years or older.
- A Phase 3, Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of Tenofovir Alafenamide (TAF) 25 mg QD Versus Tenofovir Disoproxil Fumarate (TDF) 300 mg QD for the Treatment of HBeAg-Negative, Chronic Hepatitis B.
Tenofovir alafenamide; Tenofovir DF; Placebo to match tenofovir alafenamide; Placebo to match tenofovir DF

HBV, or Chronic HBV Infections Clinical Trial using Tenofovir alafenamide; Tenofovir disoproxil fumarate; Placebo to match tenofovir alafenamide; Placebo to match tenofovir DF

Gilead Sciences - Recruiting 18 years or older.
- A Phase 3, Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of Tenofovir Alafenamide (TAF) 25 mg QD Versus Tenofovir Disoproxil Fumarate (TDF) 300 mg QD for the Treatment of HBeAg Positive, Chronic Hepatitis B.
Tenofovir alafenamide; Tenofovir disoproxil fumarate; Placebo to match tenofovir alafenamide; Placebo to match tenofovir DF

Liver Cirrhosis Clinical Trial using entecavir; Thymosin-à

Beijing Friendship Hospital - Recruiting 18 years to 65 years.
- Optimized Treatment and Regression of HBV-induced Early Cirrhosis.
entecavir; Thymosin-à

Hepatitis B Clinical Trial

University Health Network, Toronto - Recruiting 18 years to 90 years.
- Apoptosis and Hepatitis B: The Role of Apoptosis in Patients Who Are HBeAg Negative, Have Normal ALT, and HBV DNA ò10,000 Copies/mL.